Health
Johnson & Johnson COVID-19 vaccine linked to potentially paralysing Guillain-Barré syndrome – 7NEWS.com.au
Just weeks ago, the TGA granted the vaccine provisional approval for use in Australia.
There are fears some recipients of Johnson & Johnsons coronavirus vaccine face an increased risk of a rare neurological complication known as Guillain-Barre syndrome (GBS) after an increase in reports of the sometimes paralysing condition.
The US Food and…
Continue Reading
-
Noosa News15 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business20 hours agoFord CEO makes stunning prediction about artificial intelligence
-
General21 hours agoRush to buy homes before rate cuts send prices soaring
-
Business18 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025